Literature DB >> 15015008

Incidence rates and determinants in meralgia paresthetica in general practice.

A M van Slobbe1, A M Bohnen, R M D Bernsen, B W Koes, S M A Bierma-Zeinstra.   

Abstract

OBJECTIVE: To determine incidence rates for meralgia paresthetica (MP) in the primary care setting and establish determinants for MP in a case-control study in general practices.
METHODS: Using a cohort (in total 173,375 patient years) of registered persons in primary care from a computerized registration network for general practitioners (GPs) in the Rotterdam area from 1990 to 1998, persons with the diagnosis MP were included. In a nested case-control study we studied the relationship between comorbidity (e. g. carpal tunnel syndrome, pregnancy, osteoarthritis of the hip, overweight, symptoms of the pubic bone, thrombosis of the leg, diabetes mellitus and the use of corticosteroids) and the occurrence of MP.
RESULTS: The incidence rate of MP is 4.3 per 10,000 person years. MP is more often present in patients suffering from carpal tunnel syndrome OR 7.7 (95 % CI 1.9-31.1) and is related to pregnancy OR 12.0 (95 % CI 1.2-118.0).
CONCLUSIONS: This is the first report on incidence rates of MP and on suspected determinants studied in a case-control setting in general practice. Carpal tunnel syndrome and pregnancy are significantly related to MP. Calculating the Population Attributable Risk in this study leaves 79% of all MP unexplained. Our results suggest that MP is caused by a combined susceptibility for entrapment and a trigger causing entrapment. More research on determinants is needed. Because MP occurs in every GP practice at least once a year more studies are needed on prognosis and treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15015008     DOI: 10.1007/s00415-004-0310-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  18 in total

1.  Chronic meralgia paresthetica and neurectomy: a clinical pathologic study.

Authors:  Sarah E Berini; Robert J Spinner; Mark E Jentoft; Janean K Engelstad; Nathan P Staff; Narupat Suanprasert; P James B Dyck; Christopher J Klein
Journal:  Neurology       Date:  2014-03-28       Impact factor: 9.910

2.  Lawnmower neuritis: an unusual occupational hazard.

Authors:  Hu Liang Low; George Stephenson
Journal:  CMAJ       Date:  2005-05-10       Impact factor: 8.262

3.  Meralgia paraesthetica (Bernhardt-Roth syndrome).

Authors:  J M S Pearce
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

4.  Meralgia paresthetica affecting parturient women who underwent cesarean section -A case report-.

Authors:  Kum Hee Chung; Jong Yeon Lee; Tong Kyun Ko; Chung Hyun Park; Duk Hee Chun; Hyeon Jeong Yang; Hyun Jue Gill; Min Ku Kim
Journal:  Korean J Anesthesiol       Date:  2010-12-31

5.  Beneath the Surface: Massive Retroperitoneal Liposarcoma Masquerading as Meralgia Paresthetica.

Authors:  John W Ostrominski; Qin Huang; Yelena Kamenker-Orlov
Journal:  Fed Pract       Date:  2021-05

Review 6.  Treatment for meralgia paraesthetica.

Authors:  Nofal Khalil; Alessia Nicotra; Wojtek Rakowicz
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

7.  Preoperative Ultrasound-Guided Wire Localization of the Lateral Femoral Cutaneous Nerve.

Authors:  Amgad S Hanna; Mark E Ehlers; Kenneth S Lee
Journal:  Oper Neurosurg (Hagerstown)       Date:  2017-06-01       Impact factor: 2.703

8.  [Common and not so common nerve entrapment syndromes: diagnostics, clinical aspects and therapy].

Authors:  W J Schulte-Mattler; T Grimm
Journal:  Nervenarzt       Date:  2015-02       Impact factor: 1.214

9.  Meralgia paresthetica: relation to obesity, advanced age, and diabetes mellitus.

Authors:  Thomas J Parisi; Jay Mandrekar; P James B Dyck; Christopher J Klein
Journal:  Neurology       Date:  2011-10-05       Impact factor: 9.910

Review 10.  Distal Symmetric Polyneuropathy: A Review.

Authors:  Brian C Callaghan; Raymond S Price; Eva L Feldman
Journal:  JAMA       Date:  2015-11-24       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.